| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $236.8M | +41.1% |
| Cost of Revenue | $187.3M | +12.5% |
| R&D Expense | $28.8M | -2.1% |
| SG&A Expense | $44.7M | -19.2% |
| Operating Income | -$43.2M | +58.6% |
| Pre-tax Income | -$34.7M | +65.9% |
| Income Tax | -$108K | +98.0% |
| Net Income | -$34.6M | +64.1% |
| EPS (Basic) | -$0.17 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $215.2M | +2.3% |
| Accounts Receivable | $61.9M | -0.9% |
| Inventory | $41.6M | -45.1% |
| Current Assets | $340.3M | -10.0% |
| Total Assets | $509.8M | -9.1% |
| Current Liabilities | $117.3M | -11.6% |
| Total Liabilities | $167.3M | -14.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $6.0M | +107.4% |
| Capital Expenditures | $147K | -86.8% |
| Investing Cash Flow | -$6.0M | +95.4% |
| Financing Cash Flow | -$1.9M | +32.0% |
| Free Cash Flow | $5.8M | +107.1% |
| +65.3% |
| EPS (Diluted) | -$0.17 | +65.3% |
| Stockholders' Equity |
| $342.4M |
| -6.0% |